Your browser doesn't support javascript.
loading
CD19-specific CAR T Cells that Express a PD-1/CD28 Chimeric Switch-Receptor are Effective in Patients with PD-L1-positive B-Cell Lymphoma.
Liu, Hui; Lei, Wen; Zhang, Chaoting; Yang, Chunmei; Wei, Juying; Guo, Qunyi; Guo, Xiaojun; Chen, Zhilu; Lu, Ying; Young, Ken H; Lu, Zheming; Qian, Wenbin.
Afiliação
  • Liu H; Institute of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, P.R. China.
  • Lei W; Department of Hematology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, P.R. China.
  • Zhang C; Institute of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, P.R. China.
  • Yang C; Department of Hematology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, P.R. China.
  • Wei J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Biochemistry and Molecular Biology, Peking University Cancer Hospital and Institute, Beijing, P.R. China.
  • Guo Q; Institute of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, P.R. China.
  • Guo X; Institute of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, P.R. China.
  • Chen Z; Department of Hematology, Taizhou Hospital of Zhejiang Province, Wenzhou Medical College, Linhai, Zhejiang, P.R. China.
  • Lu Y; Department of Hematology, First Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, P.R. China.
  • Young KH; Department of Hematology, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, P.R. China.
  • Lu Z; Department of Hematology, Yinzhou Hospital, Affiliated to College of Medicine, Ningbo University, Ningbo, Zhejiang, P.R. China.
  • Qian W; Division of Hematopathology, Department of Pathology, Duke University School of Medicine, Duke University Medical Center and Duke Cancer Institute, Durham, North Carolina. qianwb@zju.edu.cn luzheming@bjmu.edu.cn ken.young@duke.edu.
Clin Cancer Res ; 27(2): 473-484, 2021 01 15.
Article em En | MEDLINE | ID: mdl-33028589
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Linfócitos T / Imunoterapia Adotiva / Linfoma Difuso de Grandes Células B / Receptores de Antígenos Quiméricos Tipo de estudo: Etiology_studies Limite: Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Linfócitos T / Imunoterapia Adotiva / Linfoma Difuso de Grandes Células B / Receptores de Antígenos Quiméricos Tipo de estudo: Etiology_studies Limite: Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article